A. George Awad
Dr. Awad is a professor emeritus in the Department of Psychiatry, and on the Faculty of the School of Graduate Studies in the Institute of Medical Science, University of Toronto. Dr. Awad also serves as the Psychiatrist in Chief of the Department of Psychiatry and Mental Health at Humber River Regional Hospital in Toronto, a large department which was created by the merger of three general hospitals. Dr. Awad continues to serve as a national and international reviewer and consultant for academic and service programs. He also serves in several national and international organizations, including recently being elected as the first Founding President of the newly developed International Society for CNS Clinical Trails and Methodology (ISCTM). He also served as the eleventh president of the Canadian College of Neuropsychopharmacology. He chaired and served on a number of NIH, NIMH, CINP committees. He continues to serve as a member of the International Advisory Board to the German federal government, which oversees the network of Schizophrenia Centres of Excellence in Germany. Dr. Awad made significant contributions to the Canadian Psychiatric Research Foundation, having chaired its Professional Advisory Board for a number of years and was instrumental with support from the Tanenbaum family to establish the Tanenbaum Distinguished Scientist Award in Schizophrenia. Dr. Awad was honoured to receive such an award in 1998. In 2000, he was also awarded the Canadian College of Neuropsychopharmacology medal for meritorious contributions in psychopharmacology research, teaching and services.
Dr. Awad is recognized for his national and international contributions that has led to significant research development in such areas as quality of life, subjective tolerability to medications and patient reported outcomes, and outcomes research in general. Dr. Awad has published extensively, contributed chapters to several books, and edited four books: Evaluation of Quality of Care in Psychiatry, Disturbed Behaviour in the Elderly, Prediction of Neuroleptic Treatment Outcome in Schizophrenia.